drugset / Trial / NCT06646783
Phase IIT Trial of SNA014
NaSequentialOpen-labelDiagnostic
Summary
68Ga labeled Claudin 18.2 contrast agent combined with PET/CT for gastric or gastroesophageal junction
Timeline
- Start
- 2024-10-20
- Primary completion
- 2025-10-20
- Completion
- 2025-11-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [68Ga]Ga-NODAGA-SNA014 | Diagnostic / imaging agent | — | — |